CAUSEWAY CAPITAL MANAGEMENT LLC: ASTRAZENECA PLC (AZN): Quarterly 13F Position History
As of Q1 2026, CAUSEWAY CAPITAL MANAGEMENT LLC reported 7,421,749 shares of ASTRAZENECA PLC (AZN), worth $1.4B and representing 17.7% of its 13F equity book. Quarter-over-quarter share count change: + 6,410,851 (+634.2%) . The position first appeared in Q2 2021 and has been disclosed across 20 13F-HR filings in Pactolio's tracked window.
- 7,421,749Shares Held (Latest Filing)
- $1.4BReported Market Value (Latest Filing)
- 17.7%Portfolio Weight (% of 13F Equity Book)
- +6,410,851Quarter-over-Quarter Share Change
- +$1.3BQuarter-over-Quarter Value Change
- 7,421,749Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 20 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 7,421,749 | +6,410,851 | +634.2% | $1.4B | 17.7% | $193.8 |
| Q4 2025 | 1,010,898 | 56,473 | -5.3% | $92.9M | 1.3% | $91.9 |
| Q3 2025 | 1,067,371 | +113,923 | +11.9% | $81.9M | 1.1% | $76.7 |
| Q2 2025 | 953,448 | +95,561 | +11.1% | $66.6M | 1.1% | $69.9 |
| Q1 2025 | 857,887 | +26,017 | +3.1% | $63.1M | 1.3% | $73.5 |
| Q4 2024 | 831,870 | +341,431 | +69.6% | $54.5M | 1.2% | $65.5 |
| Q3 2024 | 490,439 | +39,851 | +8.8% | $38.2M | 0.9% | $77.9 |
| Q2 2024 | 450,588 | 45,888 | -9.2% | $35.1M | 1.0% | $78.0 |
| Q1 2024 | 496,476 | +35,754 | +7.8% | $33.6M | 0.9% | $67.8 |
| Q4 2023 | 460,722 | +105,501 | +29.7% | $31.0M | 0.8% | $67.4 |
| Q3 2023 | 355,221 | +90,875 | +34.4% | $24.1M | 0.6% | $67.7 |
| Q2 2023 | 264,346 | 59,357 | -18.3% | $18.9M | 0.5% | $71.6 |
| Q1 2023 | 323,703 | +35,083 | +12.2% | $22.5M | 0.5% | $69.4 |
| Q4 2022 | 288,620 | 15,993 | -5.3% | $19.6M | 0.6% | $67.8 |
| Q3 2022 | 304,613 | 29,284 | -8.8% | $16.7M | 0.5% | $54.8 |
| Q2 2022 | 333,897 | 74,258 | -18.2% | $22.1M | 0.6% | $66.1 |
| Q1 2022 | 408,155 | +77,683 | +23.5% | $27.1M | 0.6% | $66.3 |
| Q4 2021 | 330,472 | 16,539 | -4.8% | $19.3M | 0.4% | $58.3 |
| Q3 2021 | 347,011 | +177,228 | +104.4% | $20.8M | 0.5% | $60.1 |
| Q2 2021 | 169,783 | — | — | $10.2M | 0.2% | $59.9 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did CAUSEWAY CAPITAL MANAGEMENT LLC first disclose a AZN position in 13F-HR filings?
CAUSEWAY CAPITAL MANAGEMENT LLC first reported ASTRAZENECA PLC (AZN) on its 13F-HR filing for the period ending 2021-06-30 (Q2 2021). The position has appeared on 20 reported quarters within Pactolio's tracked window.
What was CAUSEWAY CAPITAL MANAGEMENT LLC's most recent quarter-over-quarter share-count change in AZN?
Between Q4 2025 and Q1 2026, CAUSEWAY CAPITAL MANAGEMENT LLC added 6,410,851 shares of AZN (+634.2%), bringing the total reported position to 7,421,749 shares at a market value of $1.4B.
Does the implied price-per-share represent CAUSEWAY CAPITAL MANAGEMENT LLC's cost basis in AZN?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.